Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
metastatic breast cancer
.
Show all posts
Showing posts with label
metastatic breast cancer
.
Show all posts
Thursday, February 29, 2024
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
›
The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, announced the U.S. Food and Drug Administration ...
Friday, October 7, 2022
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life
›
The researchers developed three different computer models to predict how a hypothetical set of 10,000 patients with specific types of metast...
Tuesday, March 7, 2017
Lilly Announces Results From MONARCH 1 Trial Of Abemaciclib Monotherapy
›
In continuation of my update on abemaciclib Eli Lilly and Company (NYSE: LLY) announced the results from the MONARCH 1 Phase 2 stud...
Tuesday, December 11, 2012
New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer
›
Mesupron® (see structure below) is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a rece...
›
Home
View web version
